Navigation Links


Cigarettes at Biology News

Re-analysis of cigarettes confirms tobacco companies increased addictive nicotine 11 percent

A reanalysis of nicotine yield from major brand name cigarettes sold in Massachusetts from 1997 to 2005 has confirmed that manufacturers have steadily increased the levels of this agent in cigarettes. This independent analysis, based on data submitted to the Massachusetts Department of Public Health (MDPH) by the manufacturers, found that increases in smoke nicotine yield per cigarette averaged 1...
Cigarettes at Biology Products
Cigarettes at Biology Technology
Cigarettes at Medicine News

Low-Tar Cigarettes As dangerous As High-Tar Cigarettes

Addicted smokers sometimes switch to lower tar cigarettes in hopes of continuing with their habit and hoping to not experience the consequences of higher tar cigarettes.// Non-filter cigarettes make up less than 1 percent of sales in the United States and United Kingdom. A new study shows the risk for lung cancer is the same for people who smoke medium-tar cigarettes, low-tar cigarettes, or...

Reducing Number Of Cigarettes Not Enough

Cigarette smoking is the cause of 90 percent of the world’s lung cancer cases. Smokers who substantially reduce // the number of cigarettes they smoke per day are exposed to lower amounts of a potent tobacco carcinogen, or cancer-causing agent. However, the reduction in the amount or concentration of the carcinogen exposure is often temporary and not proportional to the reduction in cigarett...

Light Cigarettes - Not So Light?

A research which examined the tobacco byproducts in the urine samples of smokers found out that people have been fooling // themselves by thinking that they are getting fewer cancer-causing substances from smoking “light” or “ultra-light” cigarettes. No significant difference was found in the amount of these dangerous byproducts in smokers’ urine, regardless of the type of cigarettes th...

British company developing ‘Safer Cigarettes

Lung cancer and other cancers are mainly caused by cigarette smoking and smoking with alcohol ten folds increases the risk of cancer occurrence. In order to reduce the risk of cigarette carcinogens, British American Tobacco company is in the process of testing //their new range of “safer cigarette” which they feel will reduce the carcinogen exposure to smokers. The company is testing t...

Nicotine patches instead of cigarettes – New Year resolutio

A new resolution has been passed in United Kingdom which allows prescription of nicotine patches to children’s above the age of 12 and pregnant women as the risk associated with smoking is higher than the danger // associated with nicotine patches as earlier the sale of nicotine patches was not allowed to children’s, pregnant and breast feeding women and people with chronic diseases such as heart...

More>>

Cigarettes at Medicine Products
Cigarettes at Medicine Technology

Next Safety, Inc.'s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery

WEST JEFFERSON, N.C.--(BUSINESS WIRE)--Jun 15, 2007 - Next Safety,Inc. has identified basic scientific mechanisms that promise torevolutionize pulmonary drug delivery. This proprietary technologyuses a stream of purified air to deliver medications deep into thepulmonary system. It is considered superior to other drug deliverysystems because it rapidly administers aerosolized drugs to thelin...
Other TagsSansAwaitPowePowePowePowePowe
(Date:8/21/2008)... IL, Aug. 21 /PRNewswire-FirstCall/ - SXC Health S...SXCI , TSX: SXC), a leading provider of,pharmacy b...hierer,President and CEO, and Jeff Park, CFO, wil...hcare Conference at the Four Seasons Hotel in Bost...ace on Wednesday, September,3, 2008 at 2:40 pm ET....
(Date:8/21/2008)... Flu Vaccination Awareness Campaign...Electing a President is Not the Only Important Cho...aithersburg, MD (PRWEB) August 21, 2008 -- A new s...at vaccination ranks next to last among things the...influenza virus. Although public health guidelines...
(Date:8/21/2008)...ous Coalition for Reproductive Choice at the Democ...RNewswire-USNewswire/ -- RCRC -- the Religious,Coa...ents at the Democratic,National Convention to high...s in the campaign. RCRC,s president, The Reverend ...d is also available for media,interviews. RCRC is ...
(Date:8/21/2008)...IA BEACH, Va., Aug. 21, 2008 /PRNewswire/ -- The A...p. Sylvester Turner of Houston has,been honored wi...is part of the AMERIGROUP Foundation,s national pr...rts by government and community,leaders in improvi...t our,nation., "Our goal is to work together with...
Breaking Medicine News(10 mins):Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 2Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 3Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 4Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 5Health News:Texas State Rep. Sylvester Turner Honored as 'Champion for Children' by The AMERIGROUP Foundation 2
(Date:8/20/2008)...ileCampus(TM) Wireless Data Communications Link Sc... Faculty, WALL, N.J., Aug. 20 /PRNewswire-FirstCa...ard: BKYI), a leader in finger-based biometric,ide...today announced the,availability of MobileSRO(TM) ...rt and management solutions for K-12 schools and h...
(Date:8/20/2008)...Capital Leads Round with Additional Funding by Syn...ing Investors Including Lockheed Martin, GE Sec...RK, Aug. 20 /PRNewswire/ -- Clear(R), the fast pas...in venture funding. Led by new investor,Spark Capi...ncom Venture,Partners, and existing investors Lock...
(Date:8/20/2008)...mony watermelon? How about a strawberry-flavored b...cal School at Houston say the day may be coming wh...sponsible for flavors in fruits and vegetables. In...ly pest control. , In the advance online publica...istant Professor C.S. Raman, Ph.D., and his collea...
(Date:8/20/2008)...nd. - Engineers have created a tiny motorized ,po...imilar devices being ,developed for applications ..., powerful computer hard drives. , The device, c...,"nanoscale manipulator" that precisely moves or ... be used in watery environments for probing ,biol...
Breaking Biology News(10 mins):BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 2BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 3Clear(R) Secures $44.4 Million in Venture Funding 2Clear(R) Secures $44.4 Million in Venture Funding 3Biochemists manipulate fruit flavor enzymes 2New 'nano-positioners' may have atomic-scale precision 2New 'nano-positioners' may have atomic-scale precision 3Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 1Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 2Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 3Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 4Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 5Hodgkin Lymphoma Kids Face Greater Risk of Future Problems 20754 1Hodgkin Lymphoma Kids Face Greater Risk of Future Problems 20754 2Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 1Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 2Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 3Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 4Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 5Phase III Study of Abbotts Investigational TriLipix 28TM 29 in Combination With AstraZenecas CRESTOR 28R 29 Meets Primary Endpoints on Key Lipids 2257 1Phase III Study of Abbotts Investigational TriLipix 28TM 29 in Combination With AstraZenecas CRESTOR 28R 29 Meets Primary Endpoints on Key Lipids 2257 2Phase III Study of Abbotts Investigational TriLipix 28TM 29 in Combination With AstraZenecas CRESTOR 28R 29 Meets Primary Endpoints on Key Lipids 2257 3Phase III Study of Abbotts Investigational TriLipix 28TM 29 in Combination With AstraZenecas CRESTOR 28R 29 Meets Primary Endpoints on Key Lipids 2257 4
Other Contentsshigellosissplintssplintsshinshinglesshinglesstaturestaturestaturestatureshouldershouldershouldershouldershouldershouldershuntshuntshuntsicksicksicksick